Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CYTR $5.01 0.5100 +11.33%
ONCY $0.76 0.0710 +10.29%
FATE $5.96 0.5500 +10.17%
FPRX $24.16 1.6600 +7.38%
AVEO $1.84 0.1200 +6.98%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

BPTH $1.44 -0.1200 -7.69%
KERX $11.45 -0.8300 -6.76%
SNSS $2.64 -0.1800 -6.38%
BDSI $9.46 -0.5600 -5.59%
CLVS $86.15 -4.8400 -5.32%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk

(Bloomberg) Apr 9, 2015 - Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
read article 



Data Suggests AstraZeneca Drug May Increase Death Rate

(Reuters) Apr 10, 2015 - AstraZeneca Plc's diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of data by the U.S. Food and Drug Administration.
read article 



Roche’s Arthritis Blockbuster Holds Promise For Diabetes

(Bloomberg) Apr 9, 2015 - When the body attacks itself the consequences can be debilitating.
read article 



Woodcliff Lake-based Eisai Inc. to Cut 210 Jobs From US Workforce

(NorthJersey.com/The Record) Apr 9, 2015 - Eisai Inc., a health-care company based in Woodcliff Lake, said Thursday that it will cut its U.S. workforce by 25 percent, or 450 jobs, as it realigns its U.S. operations.
read article 



No Easy Answers for Rise in Drug Prices

(MedPage Today) Apr 9, 2015 - The current trend toward steeply rising prices for specialty drugs should not be allowed to continue, several experts said Thursday.
read article (free registration required) 



IQWiG Passes Boehringer Lung Cancer Drug

(PMLiVE [UK]) Apr 10, 2015 - IQWiG is tentatively saying yes to Boehringer's oncology drug Vargatef (nintedanib) in new guidance released this week.
read article 



Rosetta Genomics to Acquire PersonalizeDx

(Genetic Engineering & Biotechnology News) Apr 9, 2015 - Rosetta Genomics said today it has agreed to acquire CynoGen, which does business as PersonalizeDx, from Prelude, in a purchase that expands the buyer’s presence and product offerings in oncology diagnostics.
read article 



Richard M. Goldberg MD Awarded Society for Translational Oncology's Pinedo Prize

(The Business Journals) Apr 10, 2015 - The Society for Translational Oncology (STO) is pleased to announce that Richard M. Goldberg, MD, internationally renowned gastrointestinal oncologist and physician-in-chief at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), has been named recipient of the 2015 Bob Pinedo Cancer Care Prize.
read article 



Many Head and Neck Cancer Survivors Don't Return to Work

(Physician's Briefing/HealthDay News) Apr 9, 2015 - Many head and neck cancer survivors do not return to work, according to a study published in the April issue of Head & Neck.
read article 



What Cancer in Clams Might Tell Us About Cancer in Humans

(Washington Post/Speaking of Science) Apr 9, 2015 - Why, the researchers wondered, had outbreaks of a leukemia-like cancer been ravaging soft-shell clams along the East Coast for decades?
read article (free registration required) 



Review Highlights Potential of Cancer Immunotherapy Plus Targeted Therapy

(MD Anderson) Apr 9, 2015 - The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests “we are finally poised to deliver curative therapies to cancer patients,” researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell.
read press release 



Woodcliff Lake-based Eisai Inc. to Cut 25 Percent of US Workforce

(NorthJersey.com/The Record) Apr 9, 2015 - Eisai Inc., a health-care company based in Woodcliff Lake, said Thursday that it will cut its U.S. workforce by 25 percent, or 450 jobs, as it realigns its U.S. operations.
read article 



CMS to Host April 15 Call For Providers on Open Payments

(ACCC) Apr 6, 2015 - CMS is hosting a MLN Connects National Provider Call on April 15 that will provide a brief overview of the Open Payments program and highlight the parts of the program timeline when it is most critical for physicians and teaching hospitals to be aware and get involved.
read article 



Is Ipilimumab Ready For the Adjuvant Treatment of Melanoma?

(Medscape Medical News) Apr 8, 2015 – With ipilimumab already used for the treatment of first-line metastatic melanoma, how strong is the evidence for its use in the adjuvant setting?
read article (free registration required) 



Colts, IU Simon Cancer Center Launch "Chuckstrong Champion" Campaign

(Colts.com) Apr 9, 2015 - The Indianapolis Colts and the Indiana University Melvin and Bren Simon Cancer Center today launched a social media campaign to celebrate the CHUCKSTRONG Champions in our lives.
read article 



2 New Ebola Vaccines Pass Important Early Test, Researchers Say

(New York Times) Apr 8, 2015 - The vaccines protected monkeys from the virus that has killed thousands in Africa. Tests in humans will probably begin this summer.
read article 



Celladon to Report Results of Its Gene Therapy For Heart Failure: CEO

(Reuters) Apr 8, 2015 - Celladon Corp expects to report this month results from a key trial of Mydicar, its experimental gene therapy for advanced heart failure, a condition in which the heart muscle cannot pump enough blood to meet the body's needs.
read article 



Are Shortages Going Down or Not? Interpreting Data From the FDA and The University of Utah Drug Information Service

(Health Affairs blog) Apr 8, 2015 - Drug shortages are a significant public health issue that have affected many critically important drugs including chemotherapy treatments, nutritional support preparations, and antibiotics.
read article 



How the Senate Can Fix the House’s Broken Medicare Bill

(The Hill/Congress blog) Apr 9, 2015 - So, House Speaker John Boehner (R-Ohio) and Minority Leader Nancy Pelosi (D-Calif.) came up with a “doc fix”—a deal to keep Medicare doctors from being slapped with a 21 percent pay cut.
read article 



IBA and Toshiba Sign Strategic Partnership in Particle Therapy

(Toshiba) Apr 9, 2015 - IBA and Toshiba Corporation today announce the signing of a global collaboration to expand access to advanced particle therapy worldwide.
read corporate press release 



Comparing Immunotherapy to Other Cancer Weapons

(Philadelphia Inquirer) Apr 9, 2015 - When researchers talk about the new, mostly experimental form of cancer treatment known as immunotherapy, they often use glowing terms like revolutionary and transformative.
read article 



Meet the Cancer Patient in Room 52: His Name Is Joseph, But Call Him Joe

(Washington Post) Apr 8, 2015 – An ambitious program at Johns Hopkins and three other hospitals is giving top priority to improving the experience of the patient, an aspect of care that too often has been overlooked.
read article (free registration required) 



UPMC Threatens to Cut Off Medicare Advantage Access Beginning Next Year

(Pittsburgh Post-Gazette) Apr 8, 2015 - Highmark customers to be shut out on Jan. 1 if insurer does not increase cancer payments.
read article 



Meet the Cancer Doctor Who Wants the FDA to Soften Tobacco Warnings

(Washington Post/Wonkblog) Apr 8, 2015 – In a first-of-its-kind FDA hearing set for Thursday and Friday, Swedish Match is asking the FDA to soften the warning labels on its smokeless tobacco product, and the company says it has science to support its case.
read article (free registration required) 



Inovio Pharmaceuticals HPV Immunotherapy Activates Robust in Vivo T Cell Responses in Head & Neck Cancer Patients

(Yahoo! Finance) Apr 9, 2015 - Inovio Pharmaceuticals, Inc. announced today preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer associated with human papillomavirus (HPV) types 16 and 18.
read article